Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

NCT02253823 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: EFV
DRUG: TPV/RTV - low dose
DRUG: TPV/RTV - high dose

Sponsor

Boehringer Ingelheim